Company intelligence / Profile preview
Fournier
Chenôve, Francefournierindustries.com ↗
- Ownership
- Private
- Employees
- ~4376
- Development stage
- Other
01
Overview
Fournier was best known for its fenofibrate-based therapies, especially under the Lipanthyl brand, which became the most-prescribed lipid-lowering medication in Europe by the 1990s. Its lead product fenofibrate was approved in France as early as 1974 and later globally. The company also developed drugs for cardiovascular diseases and urogynecology, including estrogen-replacement systems and anti-ulcer agents. At time of acquisition by Solvay in 2005, it had a robust commercial portfolio with additional pipeline programs targeting cardiovascular and metabolic diseases.
- Therapeutic areas
- Cardiovascular
- Modalities
- Small moleculeChemical drugs
- Industry
- Biotech
02
Drug pipeline
1 asset03
Partnerships
Numerous marketing/distribution partnerships worldwidepost-acquisition R&D partnership between Abbott Laboratories and Inventiva regarding former Fournier R&D labs/assets
Beyond the preview
Go deeper on Fournier.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Fournier.